Abstract:Nevoid basal cell carcinoma syndrome (NBCCS) is an autosomal dominant disorder characterized by bone and skin abnormalities and a predisposition to various tumors. Keratocystic odontogenic tumors (KCOTs), which are common tumors of the jaw that cause extensive damage to the jawbone, are usually accompanied with NBCCS. Germline PTCH1 mutations in NBCCS tumorigenesis have been frequently studied; however, little is known regarding the pathogenesis of bone abnormalities in this disease. This study sought to investigate the mechanism underlying heterozygous PTCH1 mutation-mediated abnormal bone metabolism in patients with NBCCS. Stromal cells were isolated from the fibrous capsules of patients with NBCCS-associated or non-syndromic keratocystic odontogenic tumors and non-syndromic tumor stromal cells without PTCH1 mutations served as controls. Germline PTCH1 heterozygous mutations were confirmed in all NBCCS samples and differential protein expression was identified using tandem mass tag-labeled proteomics analysis. Our findings revealed that osteonectin/SPARC expression was significantly downregulated in syndromic stromal cells compared with non-syndromic stromal cells. SPARC expression was even lower in stromal cells carrying PTCH1 protein truncation mutations. PTCH1 siRNA transfection demonstrated that SPARC downregulation correlates with decreased PTCH1 expression. Furthermore, exogenous SPARC promoted osteogenic differentiation of syndromic stromal cells with enhanced development of calcium nodules. In addition, bone mineral density tests showed that patients with NBCCS exhibit weak bone mass compared with sex- and age-matched controls. This study indicates that germline PTCH1 heterozygous mutations play a major role in bone metabolism in patients with NBCCS, in particular in those with PTCH1 protein truncation mutations. SPARC may represent an important downstream modulator of PTCH1 mediation of bone metabolism. Thus, bone mineral density monitoring is critical for patients with NBCCS for prevention of osteoporosis. In addition, surgical procedures on syndromic-associated KCOTs should be performed with consideration of the weaker bone mass in such patients. © 2016 American Society for Bone and Mineral Research.

PTCH/SMO gene mutations in odontogenic keratocysts and drug interventions

Effect of the Sonic Hedgehog Inhibitor GDC-0449 on an in Vitro Isogenic Cellular Model Simulating Odontogenic Keratocysts

PTCH1 mutations in odontogenic keratocysts: are they related to epithelial cell proliferation?

PTCH1 and SMO gene alterations in keratocystic odontogenic tumors.

Germline Mutations Of The Ptch Gene In Families With Odontogenic Keratocysts And Nevoid Basal Cell Carcinoma Syndrome

[PTCH Gene Mutations in Odontogenic Keratocysts].

PTCH1 Alterations Are Frequent but Other Genetic Alterations Are Rare in Sporadic Odontogenic Keratocysts

Inhibition of SHH signaling pathway: molecular treatment strategy of odontogenic keratocyst.

[Studies on Keratocystic Odontogenic Tumors].

PTCH1 Gene Mutations in Keratocystic Odontogenic Tumors: A Study of 43 Chinese Patients and a Systematic Review

Detection of PTCH gene mutations in odontogenic keratocysts by SSCP and DNA sequencing]

Smoothened gene alterations in keratocystic odontogenic tumors

Mechanisms of Inactivation of PTCH1 Gene in Nevoid Basal Cell Carcinoma Syndrome: Modification of the Two-Hit Hypothesis

Identification of Known and Novel PTCH Mutations in Both Syndromic and Non-syndromic Keratocystic Odontogenic Tumors

Underestimated PTCH1 Mutation Rate in Sporadic Keratocystic Odontogenic Tumors.

Effects of PTCH1 mutations on the epithelial proliferation derived from keratocystic odontogenic tumour

Orthokeratinized Odontogenic Cysts: A Clinicopathologic Study of 159 Cases and Molecular Evidence for the Absence of PTCH1 Mutations

One germline mutation of PTCH gene in a Chinese family with non-syndromic keratocystic odontogenic tumours.

Heterozygous Ptch1 Mutations Impact the Bone Metabolism in Patients with Nevoid Basal Cell Carcinoma Syndrome Likely by Regulating Sparc Expression

BCL-2 and Ki-67 expression in Odontogenic Keratocysts

PTCH mutations in sporadic and Gorlin-syndrome-related odontogenic keratocysts.